Abstract
Several studies have shown thromboprophylaxis of any kind to be more cost-effective than no prophylaxis or general diagnostic surveillance and selective treatment. Little has been written on low molecular weight heparins from the cost-effectiveness point of view. This preliminary study shows low molecular weight heparin to be more cost-effective than standard low-dose heparin in most situations of prophylaxis.
| Original language | English |
|---|---|
| Pages (from-to) | 15-19 |
| Journal | Haemostasis |
| Volume | 23 |
| Issue number | Suppl. 1 |
| Publication status | Published - 1993 |
Bibliographical note
The information about affiliations in this record was updated in December 2015.The record was previously connected to the following departments: Emergency medicine/Medicine/Surgery (013240200)
Subject classification (UKÄ)
- Clinical Medicine